References
- Pagano L, Ricci P, Tonso A, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br J Haematol 1997; 99: 331–6
- Groote C A. Rhinocerebral Phycomycosis. Arch Otolaryngol 1970; 92: 288–92
- Leenders A C, Daenen S, Jansen RL, et al. Liposomal amphotericin B compared with amphotericin 8 deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol 1998; 103: 205–12
- Chiou C C, Groll A H, Walsh T J. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. The Oncologist 2000; 5: 120–35
- Boutati El, Maltezou H C, Lopez-Berestein G, et al (1995) Phase I study of maximum tolerated dose of intravenous liposomal nystatin for the treatment of refractory febrile neutropenia in patients with hematological malignancies. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1995. American Society for Microbiology, Abstr: LB-1
- Couch L, Theilen F, Mader J T. Rhinocerebral Mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen. Arch Otolaryngol 1988; 114: 791–4
- Gudewicz T M, Mader J T, Davis C P. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans. Aviat Space Environ Med 1987; 58: 673–8
- Rodriguez-Adrian JILJ, Grazziutti M L, Rex JH, et al. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?. Clin Inf Dis 1998; 26: 1270–8
- Rowe J M, Anderson J W, Mazza JJ, et al. A randomized placebo-controlled phase III study of GM-CSF in adult patients (>55 to 70 years of age) with AML: a study of the Eastern Cooperative Oncology Group (ECOG E1490). Blood 1995; 86: 457–62
- Peters B G, Adkins D R, Harrison BR, et al. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis. Bone Marrow Transpl 1996; 18: 93–102
- Palau L A, Pankey G A. Resolution of rhinocerehral and disseminated mucormycosis with adjuvant administration of subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF). Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, OntarioCanada, 1997. American Society for Microbiology, abstr: LM-55